Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where G. Ghobadi is active.

Publication


Featured researches published by G. Ghobadi.


International Journal of Radiation Oncology Biology Physics | 2012

Physiological interaction of heart and lung in thoracic irradiation

G. Ghobadi; Sonja J. van der Veen; Beatrijs Bartelds; Rudolf A. de Boer; Michael G. Dickinson; Johan R. de Jong; Hette Faber; Maarten Niemantsverdriet; S. Brandenburg; Rolf M.F. Berger; Johannes A. Langendijk; Robert P. Coppes; Peter van Luijk

INTRODUCTION The risk of early radiation-induced lung toxicity (RILT) limits the dose and efficacy of radiation therapy of thoracic tumors. In addition to lung dose, coirradiation of the heart is a known risk factor in the development RILT. The aim of this study was to identify the underlying physiology of the interaction between lung and heart in thoracic irradiation. METHODS AND MATERIALS Rat hearts, lungs, or both were irradiated to 20 Gy using high-precision proton beams. Cardiopulmonary performance was assessed using breathing rate measurements and F(18)-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) scans biweekly and left- and right-sided cardiac hemodynamic measurements and histopathology analysis at 8 weeks postirradiation. RESULTS Two to 12 weeks after heart irradiation, a pronounced defect in the uptake of (18)F-FDG in the left ventricle (LV) was observed. At 8 weeks postirradiation, this coincided with LV perivascular fibrosis, an increase in LV end-diastolic pressure, and pulmonary edema in the shielded lungs. Lung irradiation alone not only increased pulmonary artery pressure and perivascular edema but also induced an increased LV relaxation time. Combined irradiation of lung and heart induced pronounced increases in LV end-diastolic pressure and relaxation time, in addition to an increase in right ventricle end-diastolic pressure, indicative of biventricular diastolic dysfunction. Moreover, enhanced pulmonary edema, inflammation and fibrosis were also observed. CONCLUSIONS Both lung and heart irradiation cause cardiac and pulmonary toxicity via different mechanisms. Thus, when combined, the loss of cardiopulmonary performance is intensified further, explaining the deleterious effects of heart and lung coirradiation. Our findings show for the first time the physiological mechanism underlying the development of a multiorgan complication, RILT. Reduction of dose to either of these organs offers new opportunities to improve radiation therapy treatment of thoracic tumors, potentially facilitating increased treatment doses and tumor control.


International Journal of Radiation Oncology Biology Physics | 2010

QUANTIFYING LOCAL RADIATION-INDUCED LUNG DAMAGE FROM COMPUTED TOMOGRAPHY

G. Ghobadi; Laurens E. Hogeweg; Hette Faber; Wim Tukker; Jacobus M. Schippers; S. Brandenburg; Johannes A. Langendijk; Robert P. Coppes; Peter van Luijk

PURPOSE Optimal implementation of new radiotherapy techniques requires accurate predictive models for normal tissue complications. Since clinically used dose distributions are nonuniform, local tissue damage needs to be measured and related to local tissue dose. In lung, radiation-induced damage results in density changes that have been measured by computed tomography (CT) imaging noninvasively, but not yet on a localized scale. Therefore, the aim of the present study was to develop a method for quantification of local radiation-induced lung tissue damage using CT. METHODS AND MATERIALS CT images of the thorax were made 8 and 26 weeks after irradiation of 100%, 75%, 50%, and 25% lung volume of rats. Local lung tissue structure (S(L)) was quantified from local mean and local standard deviation of the CT density in Hounsfield units in 1-mm(3) subvolumes. The relation of changes in S(L) (DeltaS(L)) to histologic changes and breathing rate was investigated. Feasibility for clinical application was tested by applying the method to CT images of a patient with non-small-cell lung carcinoma and investigating the local dose-effect relationship of DeltaS(L). RESULTS In rats, a clear dose-response relationship of DeltaS(L) was observed at different time points after radiation. Furthermore, DeltaS(L) correlated strongly to histologic endpoints (infiltrates and inflammatory cells) and breathing rate. In the patient, progressive local dose-dependent increases in DeltaS(L) were observed. CONCLUSION We developed a method to quantify local radiation-induced tissue damage in the lung using CT. This method can be used in the development of more accurate predictive models for normal tissue complications.


Radiotherapy and Oncology | 2015

ACE inhibition attenuates radiation-induced cardiopulmonary damage

Sonja J. van der Veen; G. Ghobadi; Rudolf A. de Boer; Hette Faber; Megan V. Cannon; Peter W. Nagle; S. Brandenburg; Johannes A. Langendijk; Peter van Luijk; Robert P. Coppes

BACKGROUND AND PURPOSE In thoracic irradiation, the maximum radiation dose is restricted by the risk of radiation-induced cardiopulmonary damage and dysfunction limiting tumor control. We showed that radiation-induced sub-clinical cardiac damage and lung damage in rats mutually interact and that combined irradiation intensifies cardiopulmonary toxicity. Unfortunately, current clinical practice does not include preventative measures to attenuate radiation-induced lung or cardiac toxicity. Here, we investigate the effects of the ACE inhibitor captopril on radiation-induced cardiopulmonary damage. MATERIAL AND METHODS After local irradiation of rat heart and/or lungs captopril was administered orally. Cardiopulmonary performance was assessed using biweekly breathing rate measurements. At 8 weeks post-irradiation, cardiac hemodynamics were measured, CT scans and histopathology were analyzed. RESULTS Captopril significantly improved breathing rate and cardiopulmonary density/structure, but only when the heart was included in the radiation field. Consistently, captopril reduced radiation-induced pleural and pericardial effusion and cardiac fibrosis, resulting in an improved left ventricular end-diastolic pressure only in the heart-irradiated groups. CONCLUSION Captopril improves cardiopulmonary morphology and function by reducing acute cardiac damage, a risk factor in the development of radiation-induced cardiopulmonary toxicity. ACE inhibition should be evaluated as a strategy to reduce cardiopulmonary complications induced by radiotherapy to the thoracic area.


Thorax | 2012

Lung irradiation induces pulmonary vascular remodelling resembling pulmonary arterial hypertension

G. Ghobadi; Beatrijs Bartelds; van der Sonja Veen; Michael G. Dickinson; Sijtze Brandenburg; Rudolphus Berger; Johannes A. Langendijk; Robert P. Coppes; van Peter Luijk

Background Pulmonary arterial hypertension (PAH) is a commonly fatal pulmonary vascular disease that is often diagnosed late and is characterised by a progressive rise in pulmonary vascular resistance resulting from typical vascular remodelling. Recent data suggest that vascular damage plays an important role in the development of radiation-induced pulmonary toxicity. Therefore, the authors investigated whether irradiation of the lung also induces pulmonary hypertension. Methods Different sub-volumes of the rat lung were irradiated with protons known to induce different levels of pulmonary vascular damage. Results Early loss of endothelial cells and vascular oedema were observed in the irradiation field and in shielded parts of the lung, even before the onset of clinical symptoms. 8 weeks after irradiation, irradiated volume-dependent vascular remodelling was observed, correlating perfectly with pulmonary artery pressure, right ventricle hypertrophy and pulmonary dysfunction. Conclusions The findings indicate that partial lung irradiation induces pulmonary vascular remodelling resulting from acute pulmonary endothelial cell loss and consequential pulmonary hypertension. Moreover, the close resemblance of the observed vascular remodelling with vascular lesions in PAH makes partial lung irradiation a promising new model for studying PAH.


Radiotherapy and Oncology | 2015

A new CT-based method to quantify radiation-induced lung damage in patients

G. Ghobadi; Erwin M. Wiegman; Johannes A. Langendijk; Joachim Widder; Robert P. Coppes; Peter van Luijk

A new method to assess radiation-induced lung toxicity (RILT) using CT-scans was developed. It is more sensitive in detecting damage and corresponds better to physician-rated radiation pneumonitis than routinely-used methods. Use of this method may improve lung toxicity assessment and thereby facilitate development of more accurate predictive models for RILT.


International Journal of Radiation Oncology Biology Physics | 2016

Decreasing Irradiated Rat Lung Volume Changes Dose-Limiting Toxicity From Early to Late Effects

Sonja J. van der Veen; Hette Faber; G. Ghobadi; S. Brandenburg; Johannes A. Langendijk; Robert P. Coppes; Peter van Luijk

PURPOSE Technological developments in radiation therapy result in smaller irradiated volumes of normal tissue. Because the risk of radiation therapy-induced toxicity generally depends on irradiated volume, changing volume could change the dose-limiting toxicity of a treatment. Recently, in our rat model, we found that early radiation-induced lung dysfunction (RILD) was closely related to irradiated volume dependent vascular remodeling besides inflammation. The exact relationship between early and late RILD is still unknown. Therefore, in this preclinical study we investigated the dose-volume relationship of late RILD, assessed its dependence on early and late pathologies and studied if decreasing irradiated volume changed the dose-limiting toxicity. METHODS AND MATERIALS A volume of 25%, 32%, 50%, 63%, 88%, or 100% of the rat lung was irradiated using protons. Until 26 weeks after irradiation, respiratory rates were measured. Macrovascular remodeling, pulmonary inflammation, and fibrosis were assessed at 26 weeks after irradiation. For all endpoints dose-volume response curves were made. These results were compared to our previously published early lung effects. RESULTS Early vascular remodeling and inflammation correlated significantly with early RILD. Late RILD correlated with inflammation and fibrosis, but not with vascular remodeling. In contrast to the early effects, late vascular remodeling, inflammation and fibrosis showed a primarily dose but not volume dependence. Comparison of respiratory rate increases early and late after irradiation for the different dose-distributions indicated that with decreasing irradiated volumes, the dose-limiting toxicity changed from early to late RILD. CONCLUSIONS In our rat model, different pathologies underlie early and late RILD with different dose-volume dependencies. Consequently, the dose-limiting toxicity changed from early to late dysfunction when the irradiated volume was reduced. In patients, early and late RILD are also due to different pathologies. As such, new radiation techniques reducing irradiated volume might change the dose-limiting toxicity of the radiation therapy treatment.


Archive | 2014

Carbon ion induced vascular damage in the rat lung

J. Zink; T. Dettmering; M. Durante; P. van Luijk; Robert P. Coppes; C. Fournier; G. Ghobadi; Hette Faber; P. Simoniello

Bronchial carcinomas are one of the most frequent causes of death in Germany. Radiotherapy is used in progressed stages of the cancer if the tumor cannot be removed surgically. The aim of radiotherapy is to control tumor growth by the administration of a high dose while the normal tissue surrounding the tumor is intended to be spared. Charged particles have the beneficial feature of an inverse depth dose distribution which means that the normal tissue can be spared while a high dose is absorbed by the tumor [1]. However, doses to the healthy tissue may be high enough to provoke side effects like pneumonitis or fibrosis. These effects are preceded by vascular damage, which is considered to be related to the pathogenesis of pneumonitis and fibrosis [2]. Here we investigated the impact of Carbon ions on blood vessel damage in the rat lung.


Radiotherapy and Oncology | 2013

OC-0261: ACE-inhibition reduces acute cardiac damage to ameliorate radiation-induced lung dysfunction

S. van der Veen; G. Ghobadi; R.A. de Boer; Hette Faber; G.W. Bosman; S. Brandenburg; Johannes A. Langendijk; P. van Luijk; Robert P. Coppes


Radiotherapy and Oncology | 2012

206 ACE-INHIBITION REDUCES RADIATION PNEUMONITIS BY AMELIORATING ACUTE CARDIAC DAMAGE

S. van der Veen; G. Ghobadi; G.W. Bosman; Hette Faber; Johannes A. Langendijk; P. van Luijk; Robert P. Coppes


Radiotherapy and Oncology | 2012

EP-1227 CLINICAL TEST OF A NOVEL METHOD FOR THE ASSESSMENT OF RADIATION DAMAGE IN THE LUNG

Erwin M. Wiegman; G. Ghobadi; Johannes A. Langendijk; Robert P. Coppes; P. van Luijk

Collaboration


Dive into the G. Ghobadi's collaboration.

Top Co-Authors

Avatar

Robert P. Coppes

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Hette Faber

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Johannes A. Langendijk

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Peter van Luijk

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Erwin M. Wiegman

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Michael G. Dickinson

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Sonja J. van der Veen

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Beatrijs Bartelds

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Rolf M.F. Berger

University Medical Center Groningen

View shared research outputs
Researchain Logo
Decentralizing Knowledge